Relay Therapeutics, Inc. (RLAY)
18.35
-1.12
(-5.75%)
USD |
NASDAQ |
Oct 30, 16:00
18.34
0.00 (0.00%)
Pre-Market: 20:00
Relay Therapeutics 30-Day Average Daily Volume : 2.685M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.685M |
| October 29, 2026 | 2.901M |
| October 28, 2026 | 2.939M |
| October 27, 2026 | 2.916M |
| October 26, 2026 | 2.932M |
| October 23, 2026 | 2.959M |
| October 22, 2026 | 3.035M |
| October 21, 2026 | 3.078M |
| October 20, 2026 | 3.226M |
| October 19, 2026 | 3.328M |
| October 16, 2026 | 3.338M |
| October 15, 2026 | 3.350M |
| October 14, 2026 | 3.350M |
| October 13, 2026 | 3.305M |
| October 12, 2026 | 3.374M |
| October 09, 2026 | 3.397M |
| October 08, 2026 | 3.418M |
| October 07, 2026 | 3.371M |
| October 06, 2026 | 3.348M |
| October 05, 2026 | 3.307M |
| October 02, 2026 | 3.308M |
| October 01, 2026 | 3.309M |
| September 30, 2026 | 3.284M |
| September 29, 2026 | 3.266M |
| September 28, 2026 | 3.207M |
| Date | Value |
|---|---|
| September 25, 2026 | 3.197M |
| September 24, 2026 | 3.157M |
| September 23, 2026 | 3.089M |
| September 22, 2026 | 2.997M |
| September 21, 2026 | 2.965M |
| September 18, 2026 | 2.942M |
| September 17, 2026 | 2.687M |
| September 16, 2026 | 2.634M |
| September 15, 2026 | 2.632M |
| September 14, 2026 | 2.594M |
| September 11, 2026 | 2.573M |
| September 10, 2026 | 2.497M |
| September 09, 2026 | 2.461M |
| September 08, 2026 | 2.357M |
| September 04, 2026 | 2.330M |
| September 03, 2026 | 2.329M |
| September 02, 2026 | 2.280M |
| September 01, 2026 | 2.254M |
| August 31, 2026 | 2.250M |
| August 28, 2026 | 2.240M |
| August 27, 2026 | 2.220M |
| August 26, 2026 | 2.260M |
| August 25, 2026 | 2.213M |
| August 24, 2026 | 2.179M |
| August 21, 2026 | 2.170M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| SELLAS Life Sciences Group, Inc. | 6.172M |
| TG Therapeutics, Inc. | 1.609M |
| Karyopharm Therapeutics, Inc. | 3.679M |
| Spyre Therapeutics, Inc. | 1.312M |
| Akebia Therapeutics, Inc. | 7.797M |